US company NorthWest
Biotherapeutics has been allowed
to sell its brain cancer drug in
Germany, before the treatment had
finished its late-stage trial.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 11 Mar 14 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Mar 14
SIGMA Healthcare Limited has advised its shareholders that there is “no certainty” that the indicative merger proposal received from Australian Pharmaceutical Industries on Fri (PD breaking news) will result in a transaction.
PROFESSIONAL Pharmacists Australia (PPA) has ramped up a campaign negotiating on behalf of pharmacists and technicians working for Epic Pharmacy, this week publicly urging the company’s staff to join the union group as it engages in negotiations to improve pay and conditions at the hospital pharmacy provider.